Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05120713 · ClinicalTrials.gov registry record
Noradrenergic Activity and Attention
A clinical trial, sponsored by University of Southern California.
- Completed
- Registry status
- 140
- Enrollment target
NCT05120713 is a clinical trial that has completed, run by University of Southern California. The registered enrollment target is 140 participants.
The verdict
NCT05120713 has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- 140 participants
- Enrollment target
Study Summary
Older adults demonstrate increased distractibility by task-irrelevant information which contributes to general cognitive impairment. However, it is yet unclear how changes in noradrenergic activity during aging influences attentional control. In the current study, tonic noradrenergic activity will be increased or decreased to investigate its behavioral and neural effects on attentional control.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2021-11-01 |
| Est. Completion | 2023-11-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05120713
The ClinicalTrials.gov registry entry for NCT05120713 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05120713 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05120713 about?
NCT05120713 is a clinical study titled "Noradrenergic Activity and Attention". Older adults demonstrate increased distractibility by task-irrelevant information which contributes to general cognitive impairment. However, it is yet unclear how changes in noradrenergic activity during aging influences attentional control. In the current study, tonic noradrenergic activity will b...
What is the current status of trial NCT05120713?
This trial is currently completed. The enrollment target is 140 participants. The study started on 2021-11-01. Estimated completion is 2023-11-20.
Who is sponsoring clinical trial NCT05120713?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.